Literature DB >> 29519624

Evaluation of biofilm formation ability in different Candida strains and anti-biofilm effects of Fe3O4-NPs compared with Fluconazole: an in vitro study.

S Salari1, N Sadat Seddighi2, P Ghasemi Nejad Almani3.   

Abstract

OBJECTIVE: Biofilm formation ability is one of the major virulence factors contributing to the pathogenesis of Candida species. Biofilms produced by Candida spp. cause complicated treatments and contribute to increasing unpleasant mortality rates. Nanoparticles of Fe3O4 (Fe3O4-NPs) are considered due to their magnetic and biochemical properties, as well as their low costs. The purpose of present study was to determine biofilm formation ability in different Candida strains and evaluation of anti-biofilm effect of Fe3O4-NPs compared with FLC.
MATERIALS AND METHODS: In this study, the biofilm-forming ability of Candida strains and the inhibitory effects of Fe3O4-NPs on Candida strains biofilms compared with FLC were measured by MTT assay.
RESULTS: Our finding showed that the biofilm formation ability of C. lusitaniae was significantly higher than other tested Candida strains. However, all the studied Candida strains produced high degree of biofilms. The biofilm formation in different Candida strains was inhibited at concentrations ≥1000μg/mL to ≥4000μg/mL for Fe3O4-NPs and ≥512μg/mL to ≥2048μg/mL for FLC. After exposure to various concentrations of Fe3O4-NPs, biofilm formation reduction in C. albicans and C. parapsilosis were more than FLC. Although, this reduction was not significant. A significant reduction (P<0.05) was observed in biofilm formation in presence of FLC compared with Fe3O4-NPs in C. krusei, C. tropicalis, and C. lusitaniae. The inhibitory effects of Fe3O4-NPs and FLC on biofilm formation of C. glabrata were approximately equal.
CONCLUSION: In accordance with the findings, the biofilm reduction effect of FLC for C. krusei, C. tropicalis, and C. lusitaniae were statistically higher than Fe3O4-NPs.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Biofilm; Candida strains; Fe(3)O(4)-NPs; Fluconazole; MTT assay

Mesh:

Substances:

Year:  2018        PMID: 29519624     DOI: 10.1016/j.mycmed.2018.02.007

Source DB:  PubMed          Journal:  J Mycol Med        ISSN: 1156-5233            Impact factor:   2.391


  6 in total

Review 1.  Nanoparticle, a promising therapeutic strategy for the treatment of infective endocarditis.

Authors:  Qi Tong; Tao Li; Lu Jiang; Zhengjie Wang; Yongjun Qian
Journal:  Anatol J Cardiol       Date:  2022-02       Impact factor: 1.596

2.  Fused Deposition Modeling 3D Printing: Test Platforms for Evaluating Post-Fabrication Chemical Modifications and In-Vitro Biological Properties.

Authors:  Petra Arany; Eszter Róka; Laurent Mollet; Anthony W Coleman; Florent Perret; Beomjoon Kim; Renátó Kovács; Adrienn Kazsoki; Romána Zelkó; Rudolf Gesztelyi; Zoltán Ujhelyi; Pálma Fehér; Judit Váradi; Ferenc Fenyvesi; Miklós Vecsernyés; Ildikó Bácskay
Journal:  Pharmaceutics       Date:  2019-06-13       Impact factor: 6.321

Review 3.  Current Aspects in the Biology, Pathogeny, and Treatment of Candida krusei, a Neglected Fungal Pathogen.

Authors:  Manuela Gómez-Gaviria; Héctor M Mora-Montes
Journal:  Infect Drug Resist       Date:  2020-06-10       Impact factor: 4.003

Review 4.  Therapeutic Applications of Functional Nanomaterials for Prostatitis.

Authors:  Chun-Ping Liu; Zi-De Chen; Zi-Yan Ye; Dong-Yue He; Yue Dang; Zhe-Wei Li; Lei Wang; Miao Ren; Zhi-Jin Fan; Hong-Xing Liu
Journal:  Front Pharmacol       Date:  2021-05-28       Impact factor: 5.810

5.  Comparison of antifungal and cytotoxicity activities of titanium dioxide and zinc oxide nanoparticles with amphotericin B against different Candida species: In vitro evaluation.

Authors:  Shima Ahmadpour Kermani; Samira Salari; Pooya Ghasemi Nejad Almani
Journal:  J Clin Lab Anal       Date:  2020-09-12       Impact factor: 2.352

Review 6.  Biosynthesis of bimetallic and core-shell nanoparticles: their biomedical applications - a review.

Authors:  Mehrdad Khatami; Hajar Q Alijani; Iraj Sharifi
Journal:  IET Nanobiotechnol       Date:  2018-10       Impact factor: 1.847

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.